Charles O. Williams

Form D signer

Charles O. Williams

Chief Financial Officer and COO at Surrozen

Form D signer

Capital raised by Surrozen

$76.4M+$76.4M latest round

1 Form D filing · first filed Mar 2025 · South San Francisco, CA

CURRENT ROLE: Chief Financial Officer and COO
SECTOR: Biotech
COMPANY FILINGS: 1
TEAM ON FILE: 2
FOUNDED: 2021
30D INTEREST: 1 ↗

Career

1 company on file · founded 2021

SurrozenBiotech · South San Francisco, CAsince 2021

Chief Financial Officer and COO

Signatory on Surrozen's Form D filings · $76.4M raised across 1

Company filings

via EDGAR · Form D for Surrozen1

DateCompanyFormAmountRole on filing

Mar 26, 2025SurrozenForm D+$76.4MChief Financial Officer and COO

Form DMar 26, 2025 · Surrozen+$76.4Mas Chief Financial Officer and COO

Overview

Last filing Mar 26, 2025

Charles O. Williams is on file as Chief Financial Officer and COO at Surrozen in South San Francisco, CA. Surrozen has 1 Form D filing on record, $76.4M raised in total. Charles O. Williams appears as a signatory on the company's filings.

Teammates

Surrozen · 1

Yang Li, Ph.D.Executive Officer

Products

Surrozen · 1

SZN-1326Biologic drug

SZN-1326 is a Fzd5-targeted antibody specifically designed to treat moderate to severe ulcerative colitis by stimulating Wnt signaling in the intestinal epithelium, thereby promoting tissue repair and healing.